Anteris Technologies Global (AVR) Shares Outstanding (Weighted Average) (2024 - 2026)
Anteris Technologies Global (AVR) reported Shares Outstanding (Weighted Average) of $83.0 million for Q1 2026, up 130.5% year-over-year from $36.0 million in Q1 2025, and up 124.89% quarter-over-quarter from $36.9 million in Q4 2025.
Anteris Technologies Global (AVR) Shares Outstanding (Weighted Average) (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $83.0 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $83.0 million, up 130.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $83.0 million (up 130.5% YoY), and the FY2025 annual result was $36.9 million, up 82.25% from the prior year.
- Shares Outstanding (Weighted Average) rose to $83.0 million in Q1 2026 per AVR's latest filing, from $36.9 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $83.0 million in Q1 2026 and troughed at $17.9 million in Q1 2024.
- A 3-year average of $33.8 million and a median of $36.0 million in 2025 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) jumped 82.25% in 2025, then soared 130.5% in 2026.
- A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $20.3 million in 2024, then jumped by 82.25% to $36.9 million in 2025, then jumped by 124.89% to $83.0 million in 2026.
- Business Quant data shows AVR's Shares Outstanding (Weighted Average) at $83.0 million in Q1 2026, $36.9 million in Q4 2025, and $36.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 819.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.34 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 174.20 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.43 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Anteris Technologies Global | 779.46 Mn | 779.43 Mn | 380,000.00 | 83.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.01 Mn |
| Dec 31, 2025 | 36.91 Mn |
| Sep 30, 2025 | 36.06 Mn |
| Jun 30, 2025 | 36.04 Mn |
| Mar 31, 2025 | 36.01 Mn |
| Dec 31, 2024 | 20.25 Mn |
| Sep 30, 2024 | 19.14 Mn |
| Jun 30, 2024 | 18.45 Mn |
| Mar 31, 2024 | 17.89 Mn |